Dare Bioscience, Inc. (DARE)
NASDAQ: DARE · Delayed Price · USD
1.15
0.05 (4.55%)
At close: May 26, 2022 4:00 PM
1.14
-0.01 (-0.87%)
After-hours:May 26, 2022 5:27 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.01 | 0.63 |
| Revenue Growth (YoY) | - | - | - | - | - | - | - | 1233.33% | -99.04% | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.01 | 0.63 |
| Selling, General & Admin | 8.35 | 6.55 | 5.27 | 4.66 | 2.7 | 0.16 | 11.22 | 8.59 | 6.17 | 6.39 |
| Research & Development | 30.62 | 20.77 | 8.55 | 6.41 | 0.98 | 0.07 | 25.95 | 11.77 | 9.7 | 15.81 |
| Other Operating Expenses | 0.1 | 0.08 | 0.53 | 5.81 | 7.49 | 0.4 | 0 | 0 | 0 | 0 |
| Operating Expenses | 39.07 | 27.4 | 14.34 | 16.88 | 11.18 | 0.63 | 37.17 | 20.36 | 15.87 | 22.2 |
| Operating Income | -39.07 | -27.4 | -14.34 | -16.88 | -11.18 | -0.63 | -37.17 | -20.28 | -15.86 | -21.58 |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0 | 0.04 | 2.43 | 1.08 | 1.49 | 0.57 |
| Other Expense / Income | -0.37 | -0 | -0.08 | -0.14 | 0.32 | 0 | -0.01 | 1.98 | -0.2 | -0.04 |
| Pretax Income | -38.7 | -27.4 | -14.26 | -16.74 | -11.5 | -0.67 | -39.59 | -23.34 | -17.14 | -22.1 |
| Net Income | -38.7 | -27.4 | -14.26 | -16.74 | -11.5 | -0.67 | -39.59 | -23.34 | -17.14 | -22.1 |
| Preferred Dividends | 0 | 0.01 | 0.79 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 |
| Net Income Common | -38.7 | -27.41 | -15.05 | -16.74 | -11.5 | -0.67 | -39.59 | -23.34 | -17.14 | -22.17 |
| Shares Outstanding (Basic) | 61 | 30 | 16 | 11 | 3 | 1 | 3 | 1 | 0 | 0 |
| Shares Outstanding (Diluted) | 61 | 30 | 16 | 11 | 3 | 1 | 3 | 1 | 0 | 0 |
| Shares Change | 103.23% | 93.15% | 45.16% | 232.04% | 287.10% | -67.17% | 74.80% | 2025.95% | 12.31% | - |
| EPS (Basic) | -0.63 | -0.91 | -0.97 | -1.57 | -3.56 | -0.81 | -15.60 | -16.00 | -250.50 | -363.90 |
| EPS (Diluted) | -0.63 | -0.91 | -0.97 | -1.57 | -3.56 | -0.81 | -15.60 | -16.00 | -250.50 | -363.90 |
| Free Cash Flow Per Share | -0.47 | -0.84 | -0.85 | -0.96 | -0.79 | -0.45 | -12.65 | -13.23 | -242.88 | -347.67 |
| Gross Margin | - | - | - | - | - | - | - | 100.00% | 100.00% | 100.00% |
| Operating Margin | - | - | - | - | - | - | - | -25348.75% | -264333.33% | -3452.00% |
| Profit Margin | - | - | - | - | - | - | - | -29177.50% | -285716.67% | -3536.16% |
| Free Cash Flow Margin | - | - | - | - | - | - | - | -24057.50% | -277016.67% | -3389.60% |
| EBITDA | -38.77 | -27.52 | -14.28 | -16.73 | -11.5 | -0.63 | -36.97 | -22.13 | -15.46 | -21.19 |
| EBITDA Margin | - | - | - | - | - | - | - | -27666.25% | -257650.00% | -3390.08% |
| EBIT | -38.7 | -27.4 | -14.26 | -16.74 | -11.5 | -0.63 | -37.16 | -22.26 | -15.66 | -21.53 |
| EBIT Margin | - | - | - | - | - | - | - | -27823.75% | -260933.33% | -3445.44% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).